These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1937 related articles for article (PubMed ID: 11407799)

  • 1. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
    Fitzgerald RH; Spiro TE; Trowbridge AA; Gardiner GA; Whitsett TL; O'Connell MB; Ohar JA; Young TR;
    J Bone Joint Surg Am; 2001 Jun; 83(6):900-6. PubMed ID: 11407799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge.
    Colwell CW; Collis DK; Paulson R; McCutchen JW; Bigler GT; Lutz S; Hardwick ME
    J Bone Joint Surg Am; 1999 Jul; 81(7):932-40. PubMed ID: 10428124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study.
    Heit JA; Colwell CW; Francis CW; Ginsberg JS; Berkowitz SD; Whipple J; Peters G;
    Arch Intern Med; 2001 Oct; 161(18):2215-21. PubMed ID: 11575978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of venous thromboembolism after knee arthroplasty. A randomized, double-blind trial comparing enoxaparin with warfarin.
    Leclerc JR; Geerts WH; Desjardins L; Laflamme GH; L'Espérance B; Demers C; Kassis J; Cruickshank M; Whitman L; Delorme F
    Ann Intern Med; 1996 Apr; 124(7):619-26. PubMed ID: 8607589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty.
    Colwell CW; Berkowitz SD; Lieberman JR; Comp PC; Ginsberg JS; Paiement G; McElhattan J; Roth AW; Francis CW;
    J Bone Joint Surg Am; 2005 Oct; 87(10):2169-77. PubMed ID: 16203879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.
    Dorr LD; Gendelman V; Maheshwari AV; Boutary M; Wan Z; Long WT
    J Bone Joint Surg Am; 2007 Dec; 89(12):2648-57. PubMed ID: 18056497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Canadian Collaborative Group.
    Leclerc JR; Gent M; Hirsh J; Geerts WH; Ginsberg JS
    Arch Intern Med; 1998 Apr; 158(8):873-8. PubMed ID: 9570173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial.
    Weitz JI; Bauersachs R; Becker B; Berkowitz SD; Freitas MCS; Lassen MR; Metzig C; Raskob GE
    JAMA; 2020 Jan; 323(2):130-139. PubMed ID: 31935028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. Enoxaparin Clinical Trial Group.
    Comp PC; Spiro TE; Friedman RJ; Whitsett TL; Johnson GJ; Gardiner GA; Landon GC; Jové M;
    J Bone Joint Surg Am; 2001 Mar; 83(3):336-45. PubMed ID: 11263636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty. RD Heparin Arthroplasty Group.
    J Bone Joint Surg Am; 1994 Aug; 76(8):1174-85. PubMed ID: 8056798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement.
    Eriksson BI; Agnelli G; Cohen AT; Dahl OE; Mouret P; Rosencher N; Eskilson C; Nylander I; Frison L; Ogren M;
    Thromb Haemost; 2003 Feb; 89(2):288-96. PubMed ID: 12574809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Effectiveness and Safety of Drug Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty.
    Cafri G; Paxton EW; Chen Y; Cheetham CT; Gould MK; Sluggett J; Bini SA; Khatod M
    J Arthroplasty; 2017 Nov; 32(11):3524-3528.e1. PubMed ID: 28634095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.
    Freedman KB; Brookenthal KR; Fitzgerald RH; Williams S; Lonner JH
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):929-38. PubMed ID: 10901307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the safety and efficacy of enoxaparin and warfarin for prevention of deep vein thrombosis after total knee arthroplasty.
    Stern SH; Wixson RL; O'Connor D
    J Arthroplasty; 2000 Feb; 15(2):153-8. PubMed ID: 10708078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.
    Fiessinger JN; Huisman MV; Davidson BL; Bounameaux H; Francis CW; Eriksson H; Lundström T; Berkowitz SD; Nyström P; Thorsén M; Ginsberg JS;
    JAMA; 2005 Feb; 293(6):681-9. PubMed ID: 15701909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose warfarin for prevention of symptomatic thromboembolism after orthopedic surgery.
    Enyart JJ; Jones RJ
    Ann Pharmacother; 2005 Jun; 39(6):1002-7. PubMed ID: 15886295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of bemiparin compared with enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty: a randomized, double-blind clinical trial.
    Navarro-Quilis A; Castellet E; Rocha E; Paz-Jiménez J; Planès A;
    J Thromb Haemost; 2003 Mar; 1(3):425-32. PubMed ID: 12871445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery.
    Weitz JI; Cao C; Eriksson BI; Fisher W; Kupfer S; Raskob G; Spaeder J; Turpie AG
    Thromb Haemost; 2010 Dec; 104(6):1150-7. PubMed ID: 20886185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.
    Colwell CW; Spiro TE; Trowbridge AA; Morris BA; Kwaan HC; Blaha JD; Comerota AJ; Skoutakis VA
    J Bone Joint Surg Am; 1994 Jan; 76(1):3-14. PubMed ID: 8288662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.
    Bauer KA; Eriksson BI; Lassen MR; Turpie AG;
    N Engl J Med; 2001 Nov; 345(18):1305-10. PubMed ID: 11794149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 97.